SUMMARY
Depo®-Testosterone
testosterone cypionate injection, USP CIII
DEPO-Testosterone Injection, for intramuscular injection, contains testosterone cypionate which is the oil-soluble 17 (beta)- cyclopentylpropionate ester of the androgenic hormone testosterone. Testosterone cypionate is a white or creamy white crystalline powder, odorless or nearly so and stable in air. It is insoluble in water, freely soluble in alcohol, chloroform, dioxane, ether, and soluble in vegetable oils.
DEPO-Testosterone Injection is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone.
1. Primary hypogonadism (congenital or acquired)-testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome; or orchidectomy.
2. Hypogonadotropic hypogonadism (congenital or acquired)-idiopathic gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation.
|
NEWS HIGHLIGHTS RELATED TO DEPO-TESTOSTERONE
Media Articles Related to Depo-Testosterone (Testosterone)
The Dark Side Of Testosterone Deficiency: Type 2 Diabetes And Insulin Resistance
Source: Endocrinology News From Medical News Today [2008.10.02]
Association Between Higher Testosterone Levels And Financial Risk-Taking Behavior
Source: Endocrinology News From Medical News Today [2008.09.30]
Prenatal Testosterone Excess May Be Responsible For Low Sperm Count
Source: Fertility News From Medical News Today [2008.09.24]
Low Testosterone Could Weaken Older Men's Bones
Source: MedicineNet estradiol Specialty [2008.01.15]
Dutasteride In The Treatment Of Hormone Refractory Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2008.09.26]
Published Studies Related to Depo-Testosterone (Testosterone)
Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. [2008.08]
The Effects of Growth Hormone and/or Testosterone on Whole Body Protein Kinetics and Skeletal Muscle Gene Expression in Healthy Elderly Men: A Randomized Controlled Trial. [2008.08]
Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. [2008.07]
Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. [2008.06.05]
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss. [2008.06]
Clinical Trials Related to Depo-Testosterone (Testosterone)
A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone [Active, not recruiting]
Oral Androgens in Man-4: (Short Title: Oral T-4) [Completed]
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride [Completed]
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes [Completed]
28-Day Study of Testosterone Co-Administered With Dutasteride in Hypogonadal Men [Terminated]
|
